The various functional roles of thiamin (vitamin BI) in the living cells are well known, and its coenzyme form, thiamin diphosphate (TDP), is involved in the decarboxylation of 2-oxo acids and in the pentose phosphate shunt [1] [2] [3] [4] [5] [6] [7] . Specific clinical aspects of thiamin deficiency have been extensively reported from pathophysiological viewpoints on various diseases, such as beri-beri, Wernicke's encephalitis, and alcoholic abuse [8] [9] [10] . Also, the thiamin concentration and the erythrocyte transketolase activity in the sudden infant death syndrome have been discussed [11, 12] . The direct quantification of thiamin phosphate esters in the whole blood is of necessity to understand the physiological roles of active forms of thiamin.
Recent attention has been focussed on the HPLC analysis of thiamin in foods, pharmaceuticals, and artificial mixtures. The methods presented by Wielders and Mink [13], Roser et al. [14] , Kimura et al. [15, 16] , and others [17] [18] [19] cope withh the specific needs to determine very low concentrations of thiamin in whole blood and other materials [20, 21] .
Koyama et al. [22] applied an HPLC method for the determination of thiamin and its phosphate esters and proposed the possible synthesis of thiamin triphosphate (TTP) from TDP by the catalysis of thiamin diphosphate kinase (E.C. 2.7.4.15) in animal tissues [23] .
Recently we developed an improved HPLC method to determine the content of thiamin and its phosphate esters separately in human whole blood by postcolumn derivatization followed by fluorometric detection of thiochromes. In this report, we discussed this sensitive method for measurement of thiamin and its phosphate esters in erythrocytes. A high content of TTP was obtained with the use of CLC-ODS column. Our results imply the existence of a specific TDP kinase in human erythrocytes, and this system for TTP synthesis was examined in the presence and absence of activating and inhibitory agents.
MATERIALS AND METHODS
Reagents and chemicals. Thiamin hydrochloride was purchased from Wako Pure Chemical Industries Ltd. (Osaka), and thiamin monophosphate (TMP) and TDP from Sigma Chemical Co. (St. Louis, MO). TTP was a gift from Dr. Suzuoki at the Central Research Division, Takeda Pharmaceutical Co. (Osaka). All other chemicals were of the best grade commercially available. Reagents were prepared with pure water prepared by a Milli-Q deionization system (Millipore, Bedford).
Quantitative analyses of thiamin and its phosphate esters were carried out by a Shimadzu LC6A HPLC system equipped with Chromatopac CR-3A and spectrofluorometer (Shimadzu RF-540) as a monitoring unit. Sodium phosphate (0.1 M, monobasic) was used as a mobile phase solution after degassing by an ultrasonicator for 15 min. An alkaline ferricyanide solution (100 mg of K3Fe(CN)6 in 3.75 M NaOH) was used to oxidize thiamin to thiochrom.e, which was detected by fluorometry according to the method of Fujiwara and Matsui [24] .
Sample preparation. Venous blood samples were collected in tubes containing sodium heparinate (30 ~l per 5 ml of blood) as an anticoagulant. Whole blood samples were immediately deproteinized with cold 10% trichloroacetic acid (TCA) (a final concentration of ca. 7%), without freezing. The precipitate was removed by centrifugation at 35,000 x g for 5 min at 40°C. The supernatant was filtered through a Millipore filter (SJHV 004, 0.45 gum) and subjected to analysis or stored at --30°C. The extraction procedures are schematically shown in Fig. 1(a) .
Chromatographic procedure. For HPLC, the mobile phase solution was pumped at a flow rate of 0.7 ml/min. A 20-p1 solution containing thiamin and its phosphate esters (108-10-7 M) was loaded onto the column (Shim-pack CLC-ODS, 15 cm x 6 mm ~5) through a Rheodyne valve (Model 7125).
The post-column reactor was devised with a stainless-steel coil (1 m length and 0.5 mm ID.) and the column and reactor coil were kept at 35°C in a column oven (Shimadzu, CTO-6A). A proportional pump (Shimadzu, PRR-2A) delivered the oxidizing reagent at 0.4 ml/min; detection was performed by a spectrofluorometer (Shimadzu, RF-540) equipped with a 20-,i1 flow-through cell. The excitation was set at 372 nm and the emission was detected at 450 nm. The signal was displayed on a Chromatopac (Shimadzu CR-3A), and the peak height and retention Each peak in the deproteinized supernatant was identified by an increase in its peak height on supplementation of the sample with the respective authentic compound. The eluted peak was further confirmed by hydrolysis with acid phosphomonoesterase, which converted the phosphate esters to free thiamin. When the whole blood was first frozen and then processed for HPLC, its TTP content increased and TDP decreased for TTP.
Quantitative analysis of the blood thiamin and its phosphate esters concentrations The quantitative recovery of each compound was determined by adding authentic samples such as TTP (1 ng), TDP (2 ng), TMP (1 ng), and thiamin (1 ng) to whole blood (200-pl volume). Recovery rates were 101 .7 (± 2.3), 114.0 (± 4.4), 101.7 (± 6.5), and 105.6 (± 10.2) % (N=3) for TTP, TDP, TMP, and thiamin, respectively. The data obtained on the contents of thiamin and its phosphate esters in blood from normal human adults and children are summarized in Table 1. The TIP concentration was the highest, which was followed by TTP and TMP, in both adult and child samples. Free thiamin was hardly detectable in adults, whereas it was measurable in the blood from children. Table 2 compares the data on the total thiamin contents in human whole blood reported in this study with those reported by others. The values are very close, although the previous reports were obtained with different procedures. It is of interest that the TTP contents in human whole blood were observed to be fairly high as those of animal tissues reported by Rindi and DeGinseppe [25] , Kimura and Itokawa [2.6], and Fgi et al. [21] . Although those reports (including References 20 and 22), describe the existence of TTP in animal tissues, there have been no reports published on the TTP content of human whole blood aside from our present study. It should be focussed to the physiological roles of TTP in human erythrocyte and other tissues.
The effect of temperature on pretreatment Time-dependent change in thiamin and its phosphate ester contents of human blood at various temperatures. Since the stability and time-dependentt change of thiamin and its phosphate esters in human whole blood had not been completely examined yet, quantitative analysis was carried out by the above method using blood samples that had been allowed to stand at room temperature (17-22°C) for 1 to 6 h (Fig. 4) . TTP decreased, whereas TDP and thiamin slightly increased over the initial 1-h when the sample was kept at room temperature (shown by dotted line). When the whole blood was kept in an ice-bath, the compounds showed the same trends as those at room temperature, but the extent of change was less at 0°C (Fig. 4) . During these experiments, the total thiamin contents were almost the same at both temperatures : 57.8 (± 2.1) and 59.9 (± 3.0) ng/ml at 0°C and room temperature, respectively. These results indicate that measurement should be performed immediately after blood collection for precise determination of thiamin and its phosphate esters, otherwise the drawn blood should be kept at low temperature until analyzed.
The effects of the freezing-thawing on stability of thiamin phosphate esters. The effect of repeated freezing (-30°C)-thawing of whole blood samples on stability of thiamin phosphate esters was examined. The content of each component in a standard mixture of TTP, TDP, TMP, and thiamin in 5% TCA was gradually decreased, and TTP was especially unstable at room temperature. Although TTP was unstable even at 4°C, it was stable at -30°C for at least one week (data not shown). In order to examine the effects of freezing-thawing on the contents of thiamin and its phosphate esters, collected whole blood was treated as follows : one third of the sample was immediately deproteinized with TCA at a final concentration of ca. 7% at 0°C. One aliquot of the supernatant was used for quanti- 
Time dependent changes in proportions of TTP (®), TDP (0), TMP (A), and thiamin (LII) in whole bloods kept at room temperature (dotted line) or 0°C (solid line).
The data are shown as mean + SD (n=4). tative determination and the rest of the supernatant was subjected to determination after repetitive freezing and thawing. The data obtained indicate that the contents of thiamin and its phosphate esters were not affected for several weeks by the repetitive freezing (-30°C)-thawing (Fig. 5) . Another one third of the blood was frozen at -30°C without deproteinization. After the repetition of freezing-thawing treatment, the sample was subjected to the quantitative determination of thiamin and its phosphate esters after deproteinization. The ratio of the measured concentration of each compound is shown in Fig. 6 . Interestingly, the TTP content increased after the first thawing, while the TDP content decreased. In contrast, TTP decreased and TDP increased after the second freezing-thawing. The TDP formation became progressively greater when the freezing-thawing was repeated. The TMP and total thiamin contents did not change during this experiment. The last one third of the blood sample was divided into five 200 p1-tubes and stocked at -30°C without deproteinization . Samples were thawed, deproteinized, and used for determination of the contents of thiamin and its phosphate esters after various periods of freezing. As shown in Fig. 7 , TTP and TMP contents increased twice after three repetitions of freezing-thawing, while the TDP decreased by about 50%. The relative proportions of these compounds did not vary much after the fourth freezing-thawing. The maximum increment in TTP content reached the range of 39.6-53.2%. No increment, however, occurred after heating of a hemolysate (100°C, 3 min). These results indicate that the increment of TTP content was due to its possible synthesis from TDP, which might be catalyzed by a TDP transphosphorylase (TDP-kinase, E.C. 2.7.4.15). Since authentic TDP added to the whole blood was not the substrate, an erythrocyte protein-bound TDP is likely to have been the substrate for TTP synthesis. Thiamin-binding proteins in rats were separated by HPLC by Kimura and Itokawa [27] . We preliminarily observed that most of the TDP coeluted with protein as a protein-bound form when a hemolysate was applied onto a Sephadex G-25 column (Yamaguchi, T. et al., unpublished observations). Furthermore, the rise in TTP was completely abolished after heat treatment of the hemolysate. These preliminary data suggest the presence of TDP-kinase in human erythrocytes which requires the protein-bound TDP as substrate. Such a TDP-kinase activity was enhanced by a serum factor in a hemolysate derived from erythrocytes which had been washed with saline, whereas such an increment of TTP was not found in erythrocytes alone. From the above experiment and discussions, in order to carry out the suitable measurement of thiamin derivatives, we recommend deproteinization immediately after drawing of the blood. Freezing of whole blood without deproteinization results in artifacts. However, it would be permissible to store the supernatant after TCA pretreatment at -30°C until analysis could be performed.
The effect of divalent metals on TTP increment TDP-kinase is distributed in mammalian brain [23] and muscle [22] , and has distinguishing characteristics specific for each tissue. The brain TDP-kinase shows substrate specificity for protein-bound TDP and is inhibited by Fee, .Zn2+, and Pb2+, while the muscle TDP-kinase requires free TDP as a substrate and is markedly activated by creatine.
As discussed above, it is likely that there is a TDP kinase-catalyzed reaction (protein-TDP -I-ATP ~--protein-TTP -I-ADP) in the human erythrocyte. It is, however, necessary to distinguish the TTP synthesis due to TDP kinase from that resulting from the activity of another enzyme, for the human erythrocyte is reported to contain nucleoside diphosphate (NDP) kinase, which catalyzes the following reaction : NDP -I-ATP ---* nucleoside triphosphate + ADP. Therefore, we made a preliminary investigation of the inhibitory effects of divalent metals on synthesis of TTP from TDP and ATP. When TTP synthesis was examined by the method of Palmieri et al. [28] with protein bound-TDP, ATP, and hog NDP kinase as the enzyme source, no activity was observed. This result might indicate that protein-bound TDP would not be a substrate of hog NDPkinase for TTP synthesis. Thus, the elevated TTP might be due to catalysis by an erythrocyte-specific TDP kinase.
The effects of divalent metals, creatine, and nucleotides on TTP synthesis were next examined to distinguish the TTP synthesis system in erythrocytes from that involving brain and muscle enzymes. Table 3 summarizes their effects on TTP synthesis in the erythrocyte system. In the presence of 10 mM FeCl2, Pb (Cl04)2, THIAMIN,   ITS PHOSPHATE  ESTERS  IN BLOOD   213 or Cd(CH3COO)2, TTP concentrations were increased 2-fold while TDP contents were decreased to almost two thirds of the control. Thus, these effectors apparently activated TTP formation, whereas Fe2+ or Pb2+ acts as a strong inhibitor of the brain enzyme [23] . Neither CuSO4 (10 mM), CaCl2 (10 mM), ATP (5 mM), nor creative (5 mM) increased the amount of TTP. Consequently, the erythrocyte enzyme catalyzing the conversion of protein-bound-TDP to protein-bound TTP appears to be different from the muscle and brain enzymes [22, 23] . Finally, the effect of Fe2+ (10 mM FeCl2) on the TTP increment was examined under the same conditions as noted in Fig. 7 . The thiamin and its phosphate esters were measured at various times after the storage of whole blood in a freezer at -30°C . As shown in Fig. 8 , the contents of TTP increased by 3-fold and TDP concentrations decreased to one third, when 10 mM FeC12 was added before freezing. Isolation of the system responsible for this TTP increment and the comparison of the activity in erythrocytes with that in other tissues are now in progress.
Clinical application of the quantitative measurements of thiamin and its phosphate esters According to the established method for the measurement (see "sample preparation" under Materials and Methods), quantitative analysis was carried out on the blood of normal human children (age-matched group for dystrophics) and muscular dystrophics. Table 4 summarizes the contents of thiamin and its phosphate esters in these samples. The data for dystrophics were expressed by the clinical type of muscular dystrophy. The TTP content in dystrophic samples, except for a case of giant axonal neuropathy, was higher than that in the control group. In contrast, the TDP content, especially in Duchenne and Limb-Girdle types of muscular dystrophy, was lower than the control value. On the other hand, the TMP levels were not significantly different. When the values were expressed as Further investigations are required to clarify the physiological role(s) of TTP in erythrocytes. Understanding of the reason for the increment of TTP in dystrophic erythrocytes might shed some light on the pathogenesis of this disease, in which the ATP content and Nam-K~--ATPase activity are lowered in the erythrocytes [29, 30] .
